Deletion of the p16(INK4A) gene in ex vivo acute adult T cell lymphoma/leukemia cells and methylation of the p16(INK4A) promoter in HTLV type I-infected T cell lines

AIDS Research and Human Retroviruses

Volumn 16, Issue 8, 2000, Pages 709-713

  Trovato, Raffaella ^a   Cereseto, Anna ^a   Takemoto, Shigeki ^a   Gessain, Antoine ^b   Watanabe, Toshiki ^c   Waldmann, Thomas ^a   Franchini, Genoveffa ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INSTITUT PASTEUR   (France)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P15; PROTEIN P16; PROTEIN P16INK4A;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA METHYLATION; GENE DELETION; GENE LOCUS; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; LEUKEMIA CELL; LYMPHOMA CELL; PRIORITY JOURNAL; PROMOTER REGION; T CELL LEUKEMIA; T CELL LYMPHOMA; T LYMPHOCYTE SUBPOPULATION; VIRUS CARCINOGENESIS; CELL CULTURE; CELL LINE; GENETICS; METABOLISM; METHYLATION; PHYSIOLOGY; T LYMPHOCYTE; VIROLOGY;

CELL LINE, TRANSFORMED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENE DELETION; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; METHYLATION; PROMOTER REGIONS (GENETICS); T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0034690327     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922200308701     Document Type: Article

References (22)

1. 1. Hirama T and Koeffler HP: Role of cyclin-dependent kinase inhibitors in the development of cancer. Blood 1995;86:841-854.
2. 2. Sherr CJ and Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995;9:1149-1163.
3. 3. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS III, Johnson BE, and Skolnick MH: A cell cycle regulator potentially involved in genesis of many tumors. Science 1994;264:436-440.
4. 4. Drexler HG: Review of alterations of the cyclin-dependent kinase inhibitors INK4 family genes p15, p16, p18, and p19 in human leukemia-lymphoma cells. Leukemia 1998;12:845-859.
5. 5. Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Willson JKV, Kinzler KW, and Vogelstein B: Deletion of p16 and p15 genes in brain tumors. Cancer Res 1994;54:6353-6358.
6. 6. Batova A, Diccianni MB, Yu JC, Nobori T, Link MP, Pullen J, and Yu AL: Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia. Cancer Res 1997;57:832-836.
7. 7. Hangaishi A, Ogawa S, Imamura N, Miyawaki S, Miura Y, Uike N, Shimazaki C, Emi N, Takeyama K, Hirosawa S, Kamada N, Kobayashi Y, Takemoto Y, Kitani T, Toyama K, Ohtake S, Yazaki Y, Ueda R, and Hirai H: Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies. Blood 1996;87:4949-4958.
8. 8. Herman JG, Civin CI, Issa J-P, Collector MI, Sharkis SJ, and Baylin SB: Distinct patterns of inactivation of p15 and p16 characterize the major types of hematological malignancies. Cancer Res 1997;57:837-841.
9. 9. Ogawa S, Hangaishi A, Miyawaki S, Hirosawa S, Miura Y, Takeyama K, Kamada N, Ohtake S, Uike N, Shimazaki C, Toyama K, Hirano K, Mizoguchi H, Kobayashi Y, Furusawa S, Saito M, Emi N, Yasaki Y, Ueda R, and Hirai H: Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTSa) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies. Blood 1995;86:1548-1556.
10. INK4B/MTS2 in human leukemias and lymphomas. Cancer Res 1995;55:1436-1440.
11. CDKN2/MTS1 in human cancers. Nature Med 1995;7:686-692.
12. INK4B. Cancer Res 1996;56:722-727.
13. CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 1995;55:4531-4535.
14. 14. Herman JG, Merlo A, Mao L, Lapidus RG, Issa J-PJ, Davidson NE, Sidransky D, and Baylin SB: Inactivation of the CDKN2/p16MTS1 is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995;55: 4525-4530.
15. waf1/cip1 expression in human T-cell lymphotropic/leukemia virus type I-transformed T-cells. Blood 1996;88:1551-1560.
16. 16. Siebert R, Willers CP, Schramm A, Fossa A, Dresen IMG, Uppenkamp M, Nowrousian MR, Seeber S, and Opalka B: Homozygous loss of MTS1/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukemia cell lines. Br J Haematol 1995;91: 350-354.
17. INK4 protein induction by 5-aza 2′ deoxycytidine. Oncogene 1995;11:1211-1216.
18. 18. Franchini G, Cereseto A, Tryniszewska E, Rivadeneira E, Kislyakova T, Mulloy JC, Takemoto S, Casareto L, Nicot C, and Trovato R: Telomerase activation, rearrangement, and inhibition of cell-cycle inhibitors in human T-cells immortalized or transformed by HTLV-I. In: Molecular Pathogenesis of HTLV-I: A Current Perspective (Semmes OJ and Hammarskjold M-L, eds.). ABI Professional Publications, Arlington, Virginia, 1999, pp. 59-70.
19. 19. Low KG, Dorner LF, Fernando DB, Grossman J, Jeang K-T, and Comb MJ: Human T-cell leukemia virus type 1 tax releases cell cycle arrest induced by p16INK4a. J Virol 1997;71:1956-1962.
20. ink4a and counteracts its inhibitory activity towards CDK4, EMBO J 1996;15:1607-1614.
21. 21. Fujiwara H, Arima N, Hashimoto-Tamaoki T, Matsushita K, Ohtsubo H, Arimura K, Hidaka S, and Tei C: Alteration of p16 (CDKN2) gene is associated with interleukin-2-induced tumor cell growth in adult T cell leukemia. Exp Hematol 1999;27:1004-1009.
22. 22. Hatta Y, Hirama T, Miller CW, Yamada Y, Tomonaga M, and Koeffler HP: Homozygous deletions of p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. Blood 1995;85: 2699-2704.